vs
FITLIFE BRANDS, INC.（FTLF）与Niagen Bioscience, Inc.（NAGE）财务数据对比。点击上方公司名可切换其他公司
Niagen Bioscience, Inc.的季度营收约是FITLIFE BRANDS, INC.的1.3倍（$33.8M vs $25.9M）。Niagen Bioscience, Inc.净利率更高（12.2% vs 6.3%，领先5.9%）。FITLIFE BRANDS, INC.同比增速更快（72.6% vs 16.2%）。过去两年FITLIFE BRANDS, INC.的营收复合增速更高（25.1% vs 23.6%）
FitLife Brands, Inc.是一家健康保健企业，主营营养补充剂、运动营养产品及体重管理解决方案的研发、营销与分销，通过零售及电商渠道服务北美地区的健身爱好者、运动员及健康意识较强的消费群体。
Niagen Bioscience（原名为ChromaDex）是一家成立于1999年，总部位于加利福尼亚州洛杉矶的生物科技公司。公司业务涵盖标准品、膳食补充剂以及原料技术开发多个领域，目前在纳斯达克挂牌上市。
FTLF vs NAGE — 直观对比
营收规模更大
NAGE
是对方的1.3倍
$25.9M
营收增速更快
FTLF
高出56.4%
16.2%
净利率更高
NAGE
高出5.9%
6.3%
两年增速更快
FTLF
近两年复合增速
23.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $25.9M | $33.8M |
| 净利润 | $1.6M | $4.1M |
| 毛利率 | 34.5% | 64.1% |
| 营业利润率 | 8.8% | 12.1% |
| 净利率 | 6.3% | 12.2% |
| 营收同比 | 72.6% | 16.2% |
| 净利润同比 | -20.8% | -42.4% |
| 每股收益（稀释后） | $0.16 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FTLFNAGE
| Q4 25 | $25.9M | $33.8M | ||
| Q3 25 | $23.5M | $34.0M | ||
| Q2 25 | $16.1M | $31.1M | ||
| Q1 25 | $15.9M | $30.5M | ||
| Q4 24 | $15.0M | $29.1M | ||
| Q3 24 | $16.0M | $25.6M | ||
| Q2 24 | $16.9M | $22.7M | ||
| Q1 24 | $16.5M | $22.2M |
净利润FTLFNAGE
| Q4 25 | $1.6M | $4.1M | ||
| Q3 25 | $921.0K | $4.6M | ||
| Q2 25 | $1.7M | $3.6M | ||
| Q1 25 | $2.0M | $5.1M | ||
| Q4 24 | $2.1M | $7.2M | ||
| Q3 24 | $2.1M | $1.9M | ||
| Q2 24 | $2.6M | $-15.0K | ||
| Q1 24 | $2.2M | $-492.0K |
毛利率FTLFNAGE
| Q4 25 | 34.5% | 64.1% | ||
| Q3 25 | 37.2% | 64.5% | ||
| Q2 25 | 42.8% | 65.0% | ||
| Q1 25 | 43.1% | 63.4% | ||
| Q4 24 | 41.4% | 62.5% | ||
| Q3 24 | 43.8% | 63.5% | ||
| Q2 24 | 44.8% | 60.2% | ||
| Q1 24 | 44.0% | 60.7% |
营业利润率FTLFNAGE
| Q4 25 | 8.8% | 12.1% | ||
| Q3 25 | 9.9% | 12.5% | ||
| Q2 25 | 15.6% | 10.2% | ||
| Q1 25 | 18.6% | 15.7% | ||
| Q4 24 | 19.2% | 24.4% | ||
| Q3 24 | 19.9% | 6.3% | ||
| Q2 24 | 21.7% | -1.1% | ||
| Q1 24 | 20.4% | -3.3% |
净利率FTLFNAGE
| Q4 25 | 6.3% | 12.2% | ||
| Q3 25 | 3.9% | 13.5% | ||
| Q2 25 | 10.8% | 11.6% | ||
| Q1 25 | 12.7% | 16.6% | ||
| Q4 24 | 13.8% | 24.6% | ||
| Q3 24 | 13.3% | 7.3% | ||
| Q2 24 | 15.5% | -0.1% | ||
| Q1 24 | 13.1% | -2.2% |
每股收益（稀释后）FTLFNAGE
| Q4 25 | $0.16 | $0.05 | ||
| Q3 25 | $0.09 | $0.05 | ||
| Q2 25 | $0.18 | $0.04 | ||
| Q1 25 | $0.20 | $0.06 | ||
| Q4 24 | $0.22 | $0.10 | ||
| Q3 24 | $0.21 | $0.02 | ||
| Q2 24 | $0.27 | $0.00 | ||
| Q1 24 | $0.21 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $43.6M | $76.5M |
| 总资产 | $106.3M | $106.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FTLFNAGE
| Q4 25 | — | — | ||
| Q3 25 | — | $64.1M | ||
| Q2 25 | — | $60.3M | ||
| Q1 25 | — | $55.5M | ||
| Q4 24 | — | $44.5M | ||
| Q3 24 | — | $32.2M | ||
| Q2 24 | — | $27.7M | ||
| Q1 24 | — | $27.4M |
总债务FTLFNAGE
| Q4 25 | — | — | ||
| Q3 25 | $46.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $13.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $16.5M | — |
股东权益FTLFNAGE
| Q4 25 | $43.6M | $76.5M | ||
| Q3 25 | $41.9M | $70.7M | ||
| Q2 25 | $40.9M | $64.2M | ||
| Q1 25 | $38.9M | $55.3M | ||
| Q4 24 | $36.1M | $46.1M | ||
| Q3 24 | $34.2M | $34.4M | ||
| Q2 24 | $31.9M | $30.7M | ||
| Q1 24 | $29.4M | $29.0M |
总资产FTLFNAGE
| Q4 25 | $106.3M | $106.4M | ||
| Q3 25 | $110.0M | $98.1M | ||
| Q2 25 | $62.8M | $91.5M | ||
| Q1 25 | $62.2M | $81.3M | ||
| Q4 24 | $58.5M | $68.3M | ||
| Q3 24 | $58.6M | $56.5M | ||
| Q2 24 | $57.3M | $54.0M | ||
| Q1 24 | $55.5M | $54.1M |
负债/权益比FTLFNAGE
| Q4 25 | — | — | ||
| Q3 25 | 1.11× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.36× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.56× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $244.0K | $679.0K |
| 自由现金流经营现金流 - 资本支出 | $239.0K | — |
| 自由现金流率自由现金流/营收 | 0.9% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 0.15× | 0.16× |
| 过去12个月自由现金流最近4个季度 | $7.4M | — |
8季度趋势，按日历期对齐
经营现金流FTLFNAGE
| Q4 25 | $244.0K | $679.0K | ||
| Q3 25 | $3.7M | $3.7M | ||
| Q2 25 | $1.2M | $1.3M | ||
| Q1 25 | $2.3M | $7.9M | ||
| Q4 24 | $957.0K | $8.6M | ||
| Q3 24 | $2.0M | $3.5M | ||
| Q2 24 | $1.6M | $-264.0K | ||
| Q1 24 | $5.0M | $295.0K |
自由现金流FTLFNAGE
| Q4 25 | $239.0K | — | ||
| Q3 25 | $3.7M | — | ||
| Q2 25 | $1.2M | — | ||
| Q1 25 | $2.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $5.0M | — |
自由现金流率FTLFNAGE
| Q4 25 | 0.9% | — | ||
| Q3 25 | 15.6% | — | ||
| Q2 25 | 7.4% | — | ||
| Q1 25 | 14.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 30.4% | — |
资本支出强度FTLFNAGE
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.1% | — |
现金转化率FTLFNAGE
| Q4 25 | 0.15× | 0.16× | ||
| Q3 25 | 3.99× | 0.81× | ||
| Q2 25 | 0.68× | 0.35× | ||
| Q1 25 | 1.15× | 1.56× | ||
| Q4 24 | 0.46× | 1.20× | ||
| Q3 24 | 0.96× | 1.86× | ||
| Q2 24 | 0.60× | — | ||
| Q1 24 | 2.33× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FTLF
暂无分部数据
NAGE
| TRUNIAGEN Consumer Product | $27.5M | 81% |
| Ingredients Segment | $5.7M | 17% |
| Other | $694.0K | 2% |
